Neurochemical Research

, Volume 14, Issue 9, pp 889–897 | Cite as

Regional changes in the concentrations of glutamate, glycine, taurine, and GABA in the vitamin B-6 deficient developing rat brain: Association with neonatal seizures

  • Tomas R. Guilarte
Original Articles

Abstract

It is well known that a dietary restriction of vitamin B-6 during gestation and lactation produces spontaneous seizures in neonatal animals. Since pyridoxal phosphate, one of the biologically active forms of vitamin B-6, is the cofactor for GAD the neonatal seizures have been attributed to low levels of brain GABA as a result of cofactor depletion. Although GABA levels are significantly lower in B-6 restricted neonatal rats with spontaneous seizures, seizure activity is not present in B-6 deficient adult rats or 28 day old rats in the present study, despite significantly low levels of brain GABA. These facts suggest that depletion of GABA is not the only biochemical alteration essential for the emergence of seizures. In the present study, the effect of vitamin B-6 undernutrition on the concentrations of the neuroactive amino acids, Glu, Gly, Tau, and GABA was determined in selected regions of the developing rat brain. The results show that the concentrations of Glu, Tau, and GABA were significantly lower and GLY significantly higher in selected brain regions of the B-6 restricted 14 day old rat compared to control tissue. Most of these changes were unique to 14 days of age, the time when spontaneous seizures are observed, and not present at 28 or 56 days of age when seizures are absent. This pattern of amino acid changes in the brain and the magnitude of the changes was consistent with those measured in a variety of chemically-induced animal models of epilepsy and in human epileptic foci. The regional distribution of amino acid changes was associated with brain regions which have been suggested to be responsible for the initiation and propagation of seizure activity. Two unique findings were also made in this study. First, there was a regional brain heterogeneity in the age-associated loss of brain Tau concentrations with the pons/medulla and substantia nigra appearing to be highly vulnerable and the hippocampus quite resistant to the loss of Tau. A second finding was the normalization of the neonatal GABA deficit in most brain regions by 56 days of age. The normalization of brain GABA was present in the face of continued dietary vitamin B-6 restriction. In summary, this study shows that the neuroactive amino acids Glu, Gly, Tau, and GABA are markedly altered in the seizure-prone vitamin B-6 restricted neonatal rat brain. The alterations in the brain concentration of Glu, Gly, and Tau may play an equally important role as GABA in the underlying mechanism of seizures associated with this condition.

Key Words

Seizures glutamate glycine taurine GABA brain regions neonatal vitamin B-6 deficiency 

Abbreviations

GAD

Glutamic acid decarboxylase

GABA

gamma-aminobutyric acid

Glu

glutamate

Gly

glycine

Tau

taurine

CNS

central nervous system

CTX

cortex

HIPP

hippocampus

C/P

caudate/putamen

SN

substantia nigra

Cb

cerebellum

P/M

pons/medulla

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dakshinamurti, K. 1982. Neurobiology of Pyridoxine. In: Advances in Nutritional Res. 4:143–179.Google Scholar
  2. 2.
    Ebadi, M. 1981. Regulation and function of pyridoxal phosphate. Neurochem. Internat. 30:181–206.Google Scholar
  3. 3.
    Guilarte, T. R., Wagner, H. N. Jr., and Frost, J. J. 1987. Effects of perinatal vitamin B-6 deficiency on dopaminergic neurochemistry. J. Neurochem. 48:432–439.PubMedGoogle Scholar
  4. 4.
    Eastman, C., and Guilarte, T. R. 1989. Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line. Brain Res. (in press).Google Scholar
  5. 5.
    Guilarte, T. R., and Wagner, H. N. Jr. 1987. Increased concentrations of 3-Hydroxykynurenine in vitamin B-6 deficient neonatal rat brain. J. Neurochem. 49:1918–1926.PubMedGoogle Scholar
  6. 6.
    Coursin, D. B. 1954. Convulsive seizures in infants with pyridoxine-deficient diet. J. Amer. Med. Assoc. 154:406–408.Google Scholar
  7. 7.
    Coursin, D. B. 1965. Vitamin B-6 metabolism in infants and children. Vitamins and Hormones. 22:755–786.Google Scholar
  8. 8.
    Daniel, E. P., Kline, O. D., and Tolle, C. D. 1942. A convulsive syndrome in young rats associated with pyridoxine deficiency. J. Nutrition. 23:205–216.Google Scholar
  9. 9.
    Snyderman, S. E., Holt, L. E., Carreto, R., and Jacobs, K. 1953. Pyridoxine deficiency in the human infant. Amer. J. Clin. Nutrit. 1:200–207.Google Scholar
  10. 10.
    Wintrobe, M. M., Follis, R. H. Jr., Miller M. H., Stein, H. J., Alcayage, R., Humphreys, S., Suksta, A., and Cartwright, G. E. 1942. Pyridoxine deficiency in swine with particular reference to anemia, epileptiform convulsions, and fatty liver. Johns Hopkins Bull. 72:1–25.Google Scholar
  11. 11.
    Wiss, O., and Weber, F. 1964. Biochemical pathology of vitamin B-6 deficiency. Vitamins and Hormones. 22:495–501.PubMedGoogle Scholar
  12. 12.
    Bayoumi, R. A., Kirwan, J. R., and Smith W. R. D. 1972. Some effects of dietary vitamin B-6 deficiency and 4-deoxypyridoxine on gamma-aminobutyric acid metabolism. J. Neurochem. 19:569–576.PubMedGoogle Scholar
  13. 13.
    Ruth, R. E., and Morgan, D. G. 1986. Dietary pyridoxine and the susceptibility to limbic motor seizures in the rat. Exp. Neurol. 94:441–448.PubMedGoogle Scholar
  14. 14.
    Tews, J. K., and Lovell, R. A. 1967. The effect of a nutritional pyridoxine deficiency on free amino acids and related substances in mouse brain. J. Neurochem. 14:1–7.PubMedGoogle Scholar
  15. 15.
    aycock, J., and Kirksey, A. 1976. Influence of different levels of dietary pyridoxine on certain parameters of developing and mature brains in rats. J. Nutrition. 106:680–688.Google Scholar
  16. 16.
    Morre, D. M., Kirksey, A., and Das, G. 1978. Effect of vitamin B-6 deficiency on the developing central nervous system of the rat. Gross measurements and cytoarchitectural alterations. J. Nutrition. 108:1250–1259.Google Scholar
  17. 17.
    Wasynczuk, A., Kirksey A., and Morre D. M. 1983. Effects of maternal vitamin B-6 deficiency on specific regions of developing rat brain: The extrapyramidal motor system. J. Nutrition. 113:746–754.Google Scholar
  18. 18.
    Meldrum, B. S. 1975. Epilepsy and gamma-aminobutyric acid mediated inhibition. Int. Rev. Neurobiol. 17:1–36.PubMedGoogle Scholar
  19. 19.
    Bayoumi, R. A., and Smith, W. R. D. 1972. Some effects of dietary vitamin B-6 deficiency on gamma-aminobutyric acid metabolism in developing rat brain. J. Neurochem. 19:1883–1897.PubMedGoogle Scholar
  20. 20.
    Stephens, M. C., Havlicek, V., and Dakshinamurti, K. 1971. Pyridoxine deficiency and development of the central nervous system in the rat. J. Neurochem. 18:2407–2416.PubMedGoogle Scholar
  21. 21.
    Allen, I. C., Grieve, A., and Griffiths, R. 1986. Differential changes in the content of amino acid neurotransmitters in discrete regions of the rat brain prior to the onset and during the course of homocysteine-induced seizures. J. Neurochem. 46:1582–1592.PubMedGoogle Scholar
  22. 22.
    Nitsch, C., Schmude, B., and Hang, P. 1983. Alterations in the content of amino acids neurotransmitters before the onset and during the course of methoxypyridoxine-induced seizures in individual rabbit brain regions. J. Neurochem. 40:1571–1580.PubMedGoogle Scholar
  23. 23.
    van Gelder, N. M., Sherwin, A. L., and Rasmussen, T. 1972. Amino acid content of epileptogenic human brain: focal versus surrounding regions. Brain Res. 40:385–393.PubMedGoogle Scholar
  24. 24.
    van Gelder, N. M., Sintitsas, I., Menini, C., and Gloor, P. 1983. Feline generalized penicillin epilepsy: Changes of glutamic acid and taurine parallel the progressive increase in excitability of the cortex. Epilepsia. 24:200–213.PubMedGoogle Scholar
  25. 25.
    Wasynczuk, A., Kirksey, A., and Morre, D. M. 1983. Effect of maternal vitamin B-6 deficiency on specific regions of developing rat brain: Amino acid metabolism. J. Nutrition. 113:735–745.Google Scholar
  26. 26.
    American Institute of Nutrition. 1977. Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J. Nutrition 107:1340–1348.Google Scholar
  27. 27.
    Lasley, S. M., Greenland, R. D., and Michaelson, I. A. 1984. Determination of gamma-aminobutyric and glutamic acids in the rat brain by liquid chromatography with electrochemical detection. Life Sci. 35:1921–1930.PubMedGoogle Scholar
  28. 28.
    Guilarte, T. R. 1989. Effect of vitamin B-6 nutrition on the levels of dopamine, dopamine metabolites, dopa decarboxylase activity, tyrosine and GABA in the developing rat corpus striatum. Neurochemical Res. 14:571–578.Google Scholar
  29. 29.
    Groziak, S., Kirksey, A., and Hamaker, B. 1984. Effect of vitamin B-6 restriction on pyridoxal phosphate concentrations in developing regions of the central nervous system in rats. J. Nutrition. 114:727–732.Google Scholar
  30. 30.
    Agrawal, H. C., Davis, J. M., and Himwick, W. A. 1968. Developmental changes in mouse brain: weight, water content and free amino acids. J. Neurochem. 15:917–923.PubMedGoogle Scholar
  31. 31.
    Oja, S. S., and Piha, R. S. 1966. Changes in the concentrations of free amino acids in the rat during postnatal development. Life Sci. 5:865–870.PubMedGoogle Scholar
  32. 32.
    Sturman, J. A., and Gaull, G. E. 1975. Taurine in the brain and liver of the developing human and monkey. J. Neurochem. 25:831–835.PubMedGoogle Scholar
  33. 33.
    Sturman, J. A., Rassin, D. K., and Gaull, G. E. 1977. Taurine in developing rat brain: Maternal-fetal transfer of [35S] taurine and its fate in the neonate. J. Neurochem. 28:31–39.PubMedGoogle Scholar
  34. 34.
    Lombardini, J. B. 1976. Regional and subcellular studies on taurine in the rat central nervous system. In: Taurine. Huxtable, R. and Barbeau, A (eds.). Raven Press, New York. pp 311–326.Google Scholar
  35. 35.
    Palkovits, M., Elekes, I., Lang, T., and Patthy, A. 1986. Taurine levels in discrete brain nuclei of rats. J. Neurochem. 47:1333–1335.PubMedGoogle Scholar
  36. 36.
    Koyama, I. 1972. Amino acids in the cobalt-induced epileptogenic and non-epileptogenic cat's cortex. Can. J. Physiol. Pharmacol. 50:740–752.PubMedGoogle Scholar
  37. 37.
    Bradord, H. F., and Peterson, D. W. 1987. Excitatory amino acids in epilepsy. Molecular Aspects of Medicine 9:133–152.Google Scholar
  38. 38.
    Dodd, P. R., and Bradford, H. F. 1976. Release of amino acids from the maturing cobalt-induced epileptic focus. Brain Res. 111:377–388.PubMedGoogle Scholar
  39. 39.
    van Gelder, N. M. 1986. The hyperexcited brain: glutamic acid release and failure of inhibition. Pages 331–347,in Excitatory amino acids and Epilepsy Schwarcz, R. and Ari, Yehezkel (eds). Plenum Publishing Company.Google Scholar
  40. 40.
    Hosokawa, S., Kato, M., and Kuroiwa, Y. 1983. Topographical distribution of propagation of seizure activity in the basal ganglia during focal motor seizures in the monkey. Neurosci. Lett. 38:29–33.PubMedGoogle Scholar
  41. 41.
    Iadarola, M. J., and Gale, K. 1982. Substantia nigra: Site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science. 218:1237–1240.PubMedGoogle Scholar
  42. 42.
    McNamara, J. O., Rigsbee, L. C., and Galloway, M. T. 1983. Evidence that substantia nigra is crucial to neural network of kindled seizures. Eur. J. Pharmacol. 86:485–486.PubMedGoogle Scholar
  43. 43.
    McNamara, J. O., Galloway, M. T., Rigsbee, L. C., and Shin, C. 1984. Evidence implicating substantia nigra in regulation of kindled seizure threshold. J. Neurosci. 4:2410–2417.PubMedGoogle Scholar
  44. 44.
    Faeth, W. H., Walker, A. E., and Andy, O. J. 1954. The propagation of cortical and subcortical epileptic discharge. Epilepsia. 3:37–48.PubMedGoogle Scholar
  45. 45.
    Heath, R. G. 1976. Brain function in epilepsy: midbrain, medullary, and cerebellar interaction with the rostral forebrain. J. Neurol. Neurosurg. Psychiatry. 39:1037–1051.PubMedGoogle Scholar
  46. 46.
    Carter, C. J. 1982. Topographical distribution of possible glutamaterigic pathways from the front cortex to the striatum and substantia nigra in rats. Neuropharmacology 21:379–383.PubMedGoogle Scholar
  47. 47.
    Pycock, C. J., and Dawbarn, D. 1980. Acute motor effects of N-methyl-D-aspartic acid and kainic acid applied focally to mesencephalic dopamine cell body regions in the rat. Neurosci. Lett. 13:85–90.Google Scholar
  48. 48.
    DeSarro, G., Meldrum, B. S., and Reavill, C. 1985. Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra. Eur. J. Pharmacol. 106:175–179.Google Scholar
  49. 49.
    DeSarro, G. Patel, S., and Meldrum, B. S. 1986. Anticonvulsant action of kainate antagonist gamma-D-glutamylaminomethylsulphonic acid injected focally into the substantia nigra and entopeduncular nucleus. Eur. J. Pharmacol. 132:229–236.PubMedGoogle Scholar
  50. 50.
    Johnson, W., and Archer, P. 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:529–531.PubMedGoogle Scholar
  51. 51.
    Kleckner, N. W., and Dingledine, R. 1988. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus Oocytes. Science. 241:835–837.PubMedGoogle Scholar
  52. 52.
    van Gelder, N. M. 1976. Rectification of abnormal glutamic acid levels by taurine.in Huxtable, R., and Barbeau, A. (eds.) Taurine. Raven Press, New York. pp 293–302.Google Scholar
  53. 53.
    van Gelder, N. M. 1987. Contributions of basic neurochemistry towards a novel concept of epilepsy. Neurochemical Res. 12:111–119.Google Scholar
  54. 54.
    Lapin, I. 1981. Kynurenines and seizures. Epilepsia 22:257–265.PubMedGoogle Scholar
  55. 55.
    Pinelli, A., Ossi, C., Colombo, R., Tofanetti, O., and Spazzi, L. 1984. Experimental convulsions in rats induced by intraventricular administration of kynurenine and structurally related compounds. Neuropharmacology 23:333–337.PubMedGoogle Scholar
  56. 56.
    Guilarte, T. R., Block, L. D., and Wagner, H. N. Jr. 1988. The putative endogenous convulsant 3-hydroxykynurenine decreases benzodiazepine receptor binding affinity: Implications to seizures associated with neonatal vitamin B-6 deficiency. Pharmacol. Biochem. Beh. 30:665–668.Google Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Tomas R. Guilarte
    • 1
  1. 1.Department of Environmental Health SciencesThe Johns Hopkins University, School of Hygiene and Public HealthBaltimore

Personalised recommendations